Neurology®
The most widely read and highly cited peer-reviewed Neurology journal
Quick Search
Advanced Search
Published online before print August 10, 2005, doi:10.1212/01.wnl.0000173836.09176.c4)
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
01.wnl.0000173836.09176.c4v1
65/6/826    most recent
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, Y. -W.
Right arrow Articles by Hoffman, E. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, Y. -W.
Right arrow Articles by Hoffman, E. P.
NEUROLOGY 2005;65:826-834
© 2005 American Academy of Neurology

Early onset of inflammation and later involvement of TGFß in Duchenne muscular dystrophy

Y. -W. Chen, DVM, PhD, K. Nagaraju, DVM, PhD, M. Bakay, PhD, O. McIntyre, BS, R. Rawat, PhD, R. Shi, MD and E. P. Hoffman, PhD

From the Research Center for Genetic Medicine (Drs. Chen, Bakay, Shi, and Hoffman and O. McIntyre), Children's National Medical Center, George Washington University, Washington, DC; and the Division of Rheumatology (Drs. Nagaraju and Rawat), Department of Medicine, Johns Hopkins University, Baltimore, MD.

address correspondence and reprint requests to Dr. Yi-Wen Chen, Research Center for Genetic Medicine, Children's National Medical Center, 111 Michigan Avenue NW, Washington, DC 20010; e-mail: ychen{at}cnmcresearch.org.

Objective: To identify stage-specific induction of molecular pathology pathways in Duchenne muscular dystrophy (DMD).

Methods: We performed mRNA profiling using muscles from fetopsies, infants (aged 8 to 10 months), and symptomatic patients (aged 5 to 12 years) with DMD, and age- and sex-matched controls. We performed immunohistochemistry to determine changes at the protein level and protein localization.

Results: Activated tissue dendritic cells, expression of toll-like receptor 7, and strong induction of nuclear factor-{kappa}B pathways occurred soon after birth in DMD muscle. Two muscle wasting pathways, atrogin-1 and myostatin, were not induced at any stage of the disease. Normal muscle showed accumulation of glycolytic and oxidative metabolism capacity with increased age, but this accumulation failed in DMD. The transforming growth factor (TGF)-ß pathway was strongly induced in symptomatic patients, with expression of TGFß type II receptor and apoptosis signal-regulating kinase 1 proteins on subsets of mature DMD myofibers

Conclusions: Our data show stage-specific remodeling of human dystrophin-deficient muscle, with inflammatory pathways predominating in the presymptomatic stages and acute activation of TGFß and failure of metabolic pathways later in the disease.

Additional material related to this article can be found on the Neurology Web site. Go to www.neurology.org and scroll down the Table of Contents for the September 27 issue to find the link for this article.

This article was previously published in electronic format as an Expedited E-Pub on August 10, 2005, at www.neurology.org.

Supported by National Institutes of Health Grants 5R21AR048318 (Y.W.C.) and 5R01NS029525-09 (E.P.H), Vernon Lynch Memorial Fellowship in Arthritis Research (K.N.), Arthritis Investigator Award from National Arthritis Foundation (K.N.), Maryland Arthritis Research Centre grant (K.N.), Myositis Association grant (K.N.), Muscular Dystrophy Association Grant MDA3455 (M.B.), and donations from the Crystal Ball, Richmond, VA (M.B.).

Received February 2, 2005. Accepted in final form June 2, 2005.

Please




This article has been cited by other articles:


Home page
 Hum Mol GenetHome page
H. Li, A. Mittal, D. Y. Makonchuk, S. Bhatnagar, and A. Kumar
Matrix metalloproteinase-9 inhibition ameliorates pathogenesis and improves skeletal muscle regeneration in muscular dystrophy
Hum. Mol. Genet., July 15, 2009; 18(14): 2584 - 2598.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
R. Burdi, J.-F. Rolland, B. Fraysse, K. Litvinova, A. Cozzoli, V. Giannuzzi, A. Liantonio, G. M. Camerino, V. Sblendorio, R. F. Capogrosso, et al.
Multiple pathological events in exercised dystrophic mdx mice are targeted by pentoxifylline: outcome of a large array of in vivo and ex vivo tests
J Appl Physiol, April 1, 2009; 106(4): 1311 - 1324.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
K. Nagaraju, R. Rawat, E. Veszelovszky, R. Thapliyal, A. Kesari, S. Sparks, N. Raben, P. Plotz, and E. P. Hoffman
Dysferlin Deficiency Enhances Monocyte Phagocytosis: A Model for the Inflammatory Onset of Limb-Girdle Muscular Dystrophy 2B
Am. J. Pathol., March 1, 2008; 172(3): 774 - 785.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
B. C. Anderson, S. P. Christiansen, and L. K. McLoon
Myogenic Growth Factors Can Decrease Extraocular Muscle Force Generation: A Potential Biological Approach to the Treatment of Strabismus
Invest. Ophthalmol. Vis. Sci., January 1, 2008; 49(1): 221 - 229.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
M. Pescatori, A. Broccolini, C. Minetti, E. Bertini, C. Bruno, A. D'amico, C. Bernardini, M. Mirabella, G. Silvestri, V. Giglio, et al.
Gene expression profiling in the early phases of DMD: a constant molecular signature characterizes DMD muscle from early postnatal life throughout disease progression
FASEB J, April 1, 2007; 21(4): 1210 - 1226.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
M. L. Urso, Y.-W. Chen, A. G. Scrimgeour, P. C. Lee, K. F. Lee, and P. M. Clarkson
Alterations in mRNA expression and protein products following spinal cord injury in humans
J. Physiol., March 15, 2007; 579(3): 877 - 892.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
K. Hnia, G. Hugon, F. Rivier, A. Masmoudi, J. Mercier, and D. Mornet
Modulation of p38 Mitogen-Activated Protein Kinase Cascade and Metalloproteinase Activity in Diaphragm Muscle in Response to Free Radical Scavenger Administration in Dystrophin-Deficient Mdx Mice
Am. J. Pathol., February 1, 2007; 170(2): 633 - 643.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
E. P. Hoffman and D. Escolar
Translating Mighty Mice into Neuromuscular Therapeutics: Is Bigger Muscle Better?
Am. J. Pathol., June 1, 2006; 168(6): 1775 - 1778.
[Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
S. A. Parsons, D. P. Millay, M. A. Sargent, E. M. McNally, and J. D. Molkentin
Age-Dependent Effect of Myostatin Blockade on Disease Severity in a Murine Model of Limb-Girdle Muscular Dystrophy
Am. J. Pathol., June 1, 2006; 168(6): 1975 - 1985.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
M. Bakay, Z. Wang, G. Melcon, L. Schiltz, J. Xuan, P. Zhao, V. Sartorelli, J. Seo, E. Pegoraro, C. Angelini, et al.
Nuclear envelope dystrophies show a transcriptional fingerprint suggesting disruption of Rb-MyoD pathways in muscle regeneration
Brain, April 1, 2006; 129(4): 996 - 1013.
[Abstract] [Full Text] [PDF]